Trial Profile
A Phase IIa Clinical Trial to Test the Safety and Efficacy of Interferon Gamma Treatment in Elevating Frataxin Levels in Friedreich's Ataxia (FRDA) Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Interferon gamma-1b (Primary)
- Indications Friedreich's ataxia
- Focus Therapeutic Use
- 20 Apr 2017 Status changed from recruiting to completed.
- 12 Feb 2014 New trial record